QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction incorporation) |
(Commission |
Title of each class |
Trading |
| Large accelerated filer | ☐ | Accelerated |
☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
| Emerging |
||||||
Table of Contents
| 1 | ||||||
| Item 1. |
1 | |||||
| 1 | ||||||
| 2 | ||||||
| Unaudited Condensed Statements of Changes in Stockholders’ Deficit |
3 | |||||
| 4 | ||||||
| 5 | ||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
16 | ||||
| Item 3. |
19 | |||||
| Item 4. |
19 | |||||
| 20 | ||||||
| Item 1. |
20 | |||||
| Items 1A. |
20 | |||||
| Item 2. |
20 | |||||
| Item 3. |
21 | |||||
| Item 4. |
21 | |||||
| Item 5. |
21 | |||||
| Item 6. |
22 | |||||
| 23 | ||||||
i
Item 1. |
Financial Statements |
September 30, 2022 (unaudited) |
December 31, 2021 |
|||||||
| Assets |
||||||||
| Cash |
$ | $ | ||||||
| Other current assets |
||||||||
| |
|
|
|
|||||
| Total current assets |
||||||||
| Cash and investments held in Trust Account |
||||||||
| Other non-current assets |
||||||||
| |
|
|
|
|||||
| Total Assets |
$ | $ | ||||||
| |
|
|
|
|||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Stockholders’ Deficit: |
||||||||
| Current liabilities: |
||||||||
| Accounts payable and accrued expenses |
$ | $ | ||||||
| Promissory note – related party |
||||||||
| Due to related party |
||||||||
| |
|
|
|
|||||
| Total current liabilities |
||||||||
| Deferred underwriting compensation |
||||||||
| Derivative warrant liabilities |
||||||||
| |
|
|
|
|||||
| Total liabilities |
||||||||
| Commitments and Contingencies (Note 5) |
||||||||
| Class A ordinary shares subject to possible redemption, 0 , 2022 and $ |
||||||||
| Stockholders’ Deficit: |
||||||||
| Preferred stock, $ |
||||||||
| Class A ordinary shares, $ |
||||||||
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital |
||||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total stockholders’ deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Stockholders’ Deficit |
$ | $ | ||||||
| |
|
|
|
|||||
For the Three Months Ended September 30, 2022 |
For the Three Months Ended September 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Loss from operations |
( |
) | ( |
) | ||||
Other income: |
||||||||
Unrealized gain on change in fair value of derivative warrant liabilities |
||||||||
Income earned on cash and marketable securities held in Trust Account |
||||||||
Total other income |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||
Basic and diluted net income per share, Class A common stock |
$ | $ | ||||||
Basic and diluted weighted average shares outstanding, Class B common stock |
||||||||
Basic and diluted net income (loss) per share, Class B common stock |
$ | $ | ( |
) | ||||
For the Nine Months Ended September 30, 2022 |
For the period from April 20, 2021 (inception) through September 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Loss from operations |
( |
) | ( |
) | ||||
Other income: |
||||||||
Unrealized gain on change in fair value of derivative warrant liabilities |
||||||||
Income earned on cash and marketable securities held in Trust Account |
||||||||
Total other income |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||
Basic and diluted net income per share, Class A common stock |
$ | $ | ||||||
Basic and diluted weighted average shares outstanding, Class B common stock |
||||||||
Basic and diluted net income (loss) per share, Class B common stock |
$ | $ | ( |
) | ||||
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
| Balance as of December 31, 2021 |
$ | $ | — | $ | ( |
) | $ | ( |
) | |||||||||||
| Stock-based compensation |
— | — | — | |||||||||||||||||
| Net income |
— | — | — | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of March 31, 2022 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Stock-based compensation |
— | — | — | |||||||||||||||||
| Remeasurement of Class A ordinary shares subject to possible redemption |
— | — | ( |
) | — | ( |
) | |||||||||||||
| Net income |
— | — | — | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of June 30, 2022 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Stock-based compensation |
— | — | — | |||||||||||||||||
| Remeasurement of Class A ordinary shares subject to possible redemption |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||
| Net income |
— | — | — | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of September 30, 2022 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
| Balance as of April 20, 2021 (inception) |
$ | $ | $ | $ | ||||||||||||||||
| Issuance of founder shares |
— | |
||||||||||||||||||
| Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
| Balance as of June 30, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
| Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Balance as of September 30, 2021 |
$ | $ | |
$ | ( |
) | $ | ( |
) | |||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
For the Nine Months Ended September 30, 2022 |
For the period from April 20, 2021 (inception) through September 30, 2021 |
|||||||
| Cash Flows from Operating Activities: |
||||||||
| Net income (loss) |
$ |
$ |
( |
) | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
| Stock-based compensation |
||||||||
| Unrealized gain on change in fair value of warrant liabilities |
( |
) | ||||||
| Unrealized gain on change in fair value on marketable securities held in Trust Account |
( |
) | ||||||
| Changes in operating assets and liabilities: |
||||||||
| Deferred offering costs |
( |
) | ||||||
| Other current assets |
||||||||
| Accounts payable and accrued expenses |
||||||||
| Accrued offering and formation costs |
||||||||
| Non-current assets |
||||||||
| Due to related party |
— |
|||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Cash Flows from Financing Activities: |
||||||||
| Proceeds from sale of common stock to initial shareholders |
||||||||
| Proceeds from promissory note - related party |
||||||||
| Repayment of promissory note - related party |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash (used in) provided by financing |
( |
) |
||||||
| |
|
|
|
|||||
| Net (decrease) increase in cash |
( |
) | ||||||
| Cash, beginning of period |
||||||||
| |
|
|
|
|||||
| Cash, end of the period |
$ |
$ |
||||||
| |
|
|
|
|||||
| Supplemental disclosure of non-cash financing activities |
|
|
|
|||||
| Change in value of Class A ordinary shares subject to possible redemption |
$ | $ | ||||||
| |
|
|
|
|||||
| Accrued offering and formation costs |
$ | $ | ||||||
| |
|
|
|
|||||
| Deferred offering costs associated with proposed public offering |
$ | $ | ||||||
| |
|
|
|
|||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Offering costs allocated to Class A ordinary shares subject to possible redemption |
( |
) | ||
| Proceeds allocated to public warrants |
( |
) | ||
| Plus: |
||||
| Remeasurement of Class A ordinary shares subject to possible redemption to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption as of December 31, 2021 |
||||
| Remeasurement of Class A ordinary shares subject to possible redemption to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption as of September 30, 2022 |
$ | |||
| |
|
For the Three Months ended September 30, 2022 |
For the three months ended September 30, 2021 |
|||||||
| Class A ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income |
$ | $ | ||||||
| Denominator: |
||||||||
| Basic and diluted weighted average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Class B ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income (loss) |
$ | $ | ( |
) | ||||
| Denominator: |
||||||||
| Basic and diluted Weighted Average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ | $ | ( |
) | ||||
| |
|
|
|
|||||
For the Nine Months ended September, 2022 |
For the period from April 20, 2021 (inception) through September 30, 2021 |
|||||||
| Class A ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income |
$ | $ | ||||||
| Denominator: |
||||||||
| Basic and diluted weighted average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ | $ | ||||||
| |
|
|
|
|||||
| Class B ordinary shares |
||||||||
| Numerator: |
||||||||
| Allocation of net income (loss) |
$ | $ | ( |
) | ||||
| Denominator: |
||||||||
| Basic and diluted Weighted Average shares outstanding |
||||||||
| |
|
|
|
|||||
| Basic and diluted earnings per share |
$ | $ | ( |
) | ||||
| |
|
|
|
|||||
| • | Level 1 |
| • | Level 2 and |
| • | Level 3 |
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of |
| • | if, and only if the last reported sale price of Class A ordinary shares for any |
| • | in whole and not in part; |
| • | at a price of $ |
| • | if, and only if the Reference Value equals or exceeds $ |
| • | if, and only if the Reference Value is less than $ |
Description |
Level |
September 30, 2022 |
December 31, 2021 |
|||||||||
Assets: |
||||||||||||
Cash held in Trust Account |
1 | $ | $ | |||||||||
Liabilities |
||||||||||||
Warrant Liability - Public Warrants |
1 | $ | $ | |||||||||
Warrant Liability - Private Placement Warrants |
3 | $ | $ | |||||||||
Input |
September 30, 2022 |
December 31, 2021 |
||||||
Risk-free interest rate |
% | % | ||||||
Expected term (years) |
||||||||
Expected volatility |
% | % | ||||||
Exercise price |
$ | $ | ||||||
Unit Price (public) |
$ | $ | ||||||
Class A Ordinary Shares |
$ | $ | ||||||
Warrant Liabilities |
||||
Fair value as of December 31, 2021 |
$ | |||
Change in valuation inputs and other assumptions |
( |
) | ||
Fair value as of March 31, 2022 |
||||
Change in valuation inputs and other assumptions |
( |
) | ||
Fair value as of June 30, 2022 |
||||
Change in valuation inputs and other assumptions |
( |
) | ||
Fair value as of September 30, 2022 |
$ | |||
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
References to “we”, “us”, “our” or the “Company” are to Talon 1 Acquisition Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.
Overview
We were incorporated as a Cayman Islands exempted company and incorporated with limited liability on April 20, 2021. The Company was incorporated for the purpose of effecting a merger capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses
On November 8, 2021, the Company consummated its initial public offering (the “
The Company will have 15 months from the closing of the initial public offering (or up to 18 months from the closing of the
Pursuant to the terms of the Company’s second amended and restated memorandum and articles of association and the Trust Agreement entered into between the Company and Continental Stock Transfer & Trust Company, in order to extend the time available for the Company to consummate its initial Business Combination by an additional three months, the Company’s Sponsor or its affiliates or designees must provide advance notice at least five days prior to the date which is 15 months from the closing of our initial public offering and must deposit into the Trust Account $2,300,000 ($0.10 per share), on or prior to the date which is 15 months from the closing of our initial public offering. Any such payments would be made in the form of
If the Company is unable to complete our initial Business Combination within the Completion Window, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at
16
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities since April 20, 2021 (inception) have been organizational activities and those necessary to prepare for our initial public offering. We do not expect to generate any operating revenues until after completion of our initial
For the three months ended September 30, 2022, we had net income of $
For the three months ended September 30, 2021, we had a net loss of $
For the nine months ended
For the period from April 20, 2021 (inception) through September 30, 2021, we had a net loss of $32,266, which consisted entirely of general and administrative costs.
Liquidity and Capital Resources
On November 8, 2021, we consummated our initial public offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of our initial public offering, the underwriters fully exercised the over-allotment option, generating gross proceeds of $30,000,000.
Simultaneously with the closing of our initial public offering, the Company consummated the sale of 13,250,000 warrants at a price of $1.00 per Private Placement Warrant in a private placement to our Sponsor generating gross proceeds of $13,250,000.
A total of $235,750,000 of the proceeds from our initial public offering, a portion of the sale of the private placement warrants, the sale of the over-allotment units and the sale of the over-allotment warrants were placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
As of September 30, 2022, we had cash and marketable securities held in the Trust Account of $
As of September 30, 2022, we had cash of $
The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. As of
As of September 30, 2022, the Company had $
17
post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Net Income Per Ordinary Share
Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. On
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815,
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
18
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Off-Balance Sheet Arrangements
As of the date of this Quarterly Report on Form
Commitments and Contractual Obligations
We do not have any long term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long term liabilities, other than an agreement to pay our Sponsor a monthly fee of $10,000 for office space and administrative support. We began incurring these fees on November 3, 2021 and will continue to incur these fees monthly until the earlier of the completion of the initial
Registration Rights
The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans), are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate, payable upon the closing of the initial public offering. An additional fee of $0.35 per Unit, or $8,050,000 in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
JOBS Act
On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for
As an “emerging growth company,” we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting, (ii) provide all of the compensation disclosure that may be required of
| Quantitative and Qualitative Disclosures About Market Risk |
We are a smaller reporting company as defined by Rule 12b-2 under the Exchange Act and are not required to provide the information otherwise required under this item.
| Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
We have continued our remediation efforts in connection with the identification of the
19
PART II. OTHER INFORMATION
| Legal Proceedings |
None.
| Item 1A. | Risk Factors |
As of the date of this Quarterly Report, except as set forth below, there have been no material changes to the risk factors disclosed in our
The excise tax included in the Inflation Reduction Act of 2022 may decrease the amount of funds available for distribution in connection with a liquidation and
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the
Although we were incorporated in the Cayman Islands, there is a
| Unregistered Sales of Equity Securities and Use of Proceeds |
Unregistered Sales of Equity Securities
Simultaneously with the closing of our initial public offering, the Company completed the private sale of an aggregate of 13,250,000 warrants at a purchase price of $1.00 per private placement warrant, to our sponsor, AVi8 Acquisition LLC, generating gross proceeds to the Company of $13,250,000. The terms of the private placement warrants are substantially similar to the warrants sold as part of the units in our initial public offering, except as otherwise disclosed in the registration statement. The issuance of the
Use of Proceeds
On November 3, 2021, our registration statement on Form S-l (File No. 333-260305) was declared effective by the SEC for our initial public offering, pursuant to which we sold an aggregate of 23,000,000 units (including the issuance of 3,000,000 units as a result of the underwriters’ exercise of their over-allotment option) at an offering price to the public of $10.00 per unit for an aggregate offering price of $230,000,000, with each unit consisting of one Class A ordinary share
20
| Defaults Upon Senior Securities |
None.
| Mine Safety Disclosures |
Not applicable.
| Other Information |
None.
21
| Exhibits |
| * | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
22
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 22, 2022
| By: | /s/ Edward J. Wegel | |
| Name: | Edward J. Wegel | |
| Title: | Chief Executive Officer (principal executive officer) |
23
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Edward J. Wegel, certify that:
1. I
have reviewed this Quarterly Report on Form 10-Q for the quarter ended
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) [Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
| By: | /s/ Edward J. Wegel |
|||||||
| Edward J. Wegel | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Ryan Goepel, certify that:
1. I have
reviewed this Quarterly Report on Form 10-Q for the quarter ended
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) [Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 22, 2022 |
||||||||
| By: |
/s/ Ryan Goepel |
|||||||
| Ryan Goepel | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial and Accounting Officer) | ||||||||
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Talon 1 Acquisition Corp. (the Company) on Form 10-Q for the
quarter ended
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 22, 2022 | ||||||||
| By: | /s/ Edward J. Wegel | |||||||
| Edward J. Wegel | ||||||||
| Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Talon 1 Acquisition Corp. (the Company) on Form 10-Q for the
quarter ended
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 22, 2022 | ||||||||
| By: | /s/ Ryan Goepel | |||||||
| Ryan Goepel | ||||||||
| Chief Financial Officer | ||||||||
| (Principal Financial and Accounting Officer) | ||||||||